Text Size

7th Annual Glaucoma 360: New Horizons Forum

On February 9, 2018, Glaucoma Research Foundation will host the 7th annual Glaucoma 360 New Horizons Forum in San Francisco.

This unique meeting brings together key clinical, industry, financial, and regulatory leaders focused on glaucoma innovations with the goal to speed the translation of new ideas into clinical use to benefit patients.

Andrew Iwach, MD, director of the Glaucoma Center of San Francisco and board chair of the Glaucoma Research Foundation, explains, “New Horizons Forum brings together a wide range of potential partners focused on innovation — from a physician standpoint, we need better solutions to help patients, and this meeting fosters the necessary collaboration and partnerships needed to advance new ideas.” He adds, “The goal of Glaucoma 360 is to accelerate the process to develop new glaucoma treatments to help patients today and ultimately find a cure.”

Adrienne Graves, PhD, co-founder and co-chair of Glaucoma 360, adds, "We showcase early-stage companies who are developing new glaucoma drugs, devices, and drug delivery systems. By putting them in the room with venture capitalists, industry executives, FDA leaders, and clinicians, we hope to stimulate and facilitate key discussions and connections. It's a way for Glaucoma Research Foundation to serve as a catalyst in the development of glaucoma therapies."


Ike Ahmed, MD will deliver the 2018 Keynote Lecture

Ike K. Ahmed, MD, Medical Director, Prism Eye Institute, Assistant Professor at the University of Toronto, and Clinical Professor at the University of Utah, will deliver the Drs. Henry and Frederick Sutro Memorial Lecture, the Forum’s keynote address.

Dr. Ahmed, who also serves on the New Horizons Program Committee, remarked that it is “an excellent networking opportunity since all the key individuals involved in innovation are at Glaucoma 360.” He adds, “As a clinician, it is exciting to see what is on the horizon in the treatment of glaucoma and have a meeting focused on pushing new developments forward to improve patient outcomes.”

Topics at the 2018 meeting will include new developments in glaucoma devices, drug delivery and pharmaceuticals, and panel presentations from nationally and internationally respected leaders from venture capital, pharmaceutical, and medical device companies.

New Horizons Forum is the centerpiece of Glaucoma 360, Glaucoma Research Foundation’s signature three-day series of events planned for February 8 - 10, 2018. Additional activities include the Annual Gala to benefit Glaucoma Research Foundation’s science and patient education programs, the 22nd annual Glaucoma Symposium CME, and the 3rd Annual Optometric Glaucoma Symposium.

Glaucoma Research Foundation’s President and CEO, Thomas M. Brunner noted the importance of Glaucoma 360 and stated, “As we continue to search for a cure, we also need new and more effective treatments in the near-term to help patients preserve their vision. No one should go blind from glaucoma."

2018 will mark the 40th anniversary of Glaucoma Research Foundation, the nation’s most experienced nonprofit foundation dedicated solely to glaucoma research and education. Mr. Brunner adds, “Glaucoma 360 is an essential program to not only showcase new ideas, but also provide an environment for innovators to network and connect to advance their ideas. Patients are counting on us to do all we can to help them.”

To learn more about Glaucoma 360 and register, visit: www.glaucoma360.org.

Last reviewed on February 28, 2018

Was this helpful? Yes No